EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Artificial Intelligence–Electrocardiography to Predict Incident Atrial Fibrillation and Clinical Outcomes in Kidney Transplant Recipients

Isabel G Scalia iD, Juan M Farina iD, Mahmoud H Abdelnabi, Milagros Pereyra Pietri, Girish Pathangey iD, Ramzi Ibrahim iD, Kamal Awad, Mohammed Tiseer Abbas, Nima Baba Ali iD, Ahmed K Mahmoud, Said Alsidawi iD, D Eric Steidley und 14 weitere

Kidney360 · 2026

DOI: 10.34067/kid.0000001063 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney360, 2026. Verfasst von Isabel G Scalia und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Diseases, Mayo Clinic, Phoenix, Arizona. Hauptthemen laut MEDLINE: Kidney Transplantation, Atrial Fibrillation, Artificial Intelligence, Electrocardiography. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Key Points Atrial fibrillation after kidney transplantation is common and is associated with poor prognosis. Artificial intelligence applied to 12-lead electrocardiograms pretransplant accurately predicts the risk of new-onset atrial fibrillation in our cohort. High-risk artificial intelligence electrocardiography score was independently associated with increased risk of mortality and allograft failure.

Background

Incident atrial fibrillation (AF) is common after kidney transplantation (KTx) and is associated with worse clinical outcomes. Artificial intelligence electrocardiography (AI-ECG) algorithms have demonstrated efficacy in predicting risk of new-onset AF in the general population; however, their prognostic value in KTx recipients is relatively unknown.

Methods

Retrospective analysis was conducted on KTx recipients without AF, with at least one pretransplant ECG between 2011 and 2021 across three tertiary centers in the United States (Mayo Clinic sites in MN, AZ, and FL). A previously validated AI-ECG algorithm estimated the probability of incident AF for each patient. Based on AI-ECG probabilities, patients were categorized into high-risk and low-risk groups, with the optimal AI-ECG score cutoff determined. The incidence of new-onset AF, allograft failure, and mortality was compared between groups.

Results

Overall, 6246 patients (age 53.5±13.8 years; 58.9% male) were included. Pretransplant AI-ECG probability of AF ≥5% was the optimal cutoff for high risk of incident AF (sensitivity 72%, specificity 62%). High-risk scores were associated with true new-onset AF at 30 days (adjusted hazard ratio [aHR], 2.89; 95% confidence intervals [CI], 2.05 to 4.09; P < 0.001), 3 years (aHR, 2.54; 95% CI, 1.99 to 3.26, P < 0.001), and 5 years post-transplant (aHR, 2.48; 95% CI, 1.99 to 3.09, P < 0.001). High-risk AI-ECG scores were also associated with increased mortality (aHR, 1.56; 95% CI, 1.30 to 1.88, P < 0.001) and overall allograft failure (aHR, 1.50; 95% CI, 1.30 to 1.75, P < 0.001) through the 5-year follow-up.

Conclusions

This pretransplant AI-ECG parameter identified patients at increased risk of new-onset AF post-KTx and provided prognostic utility. Overall, this easy to obtain tool allows for risk stratification of patients who may benefit from closer monitoring, targeted risk factor modification, and early intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationAtrial FibrillationArtificial IntelligenceElectrocardiographyPostoperative ComplicationsHumansRetrospective StudiesFemaleMiddle AgedMaleIncidencePrognosisAdultRisk FactorsPrediction AlgorithmsPredictive Value of TestsRisk AssessmentAlgorithmsAged

Stichwörter der Autor:innen

artificial intelligencecardiovascular diseasekidney transplantation

Autor:innen und Institutionen

  • Department of Cardiovascular Diseases, Mayo Clinic, Phoenix, Arizona.
  • Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, Queensland, Australia.
  • Department of Kidney and Transplant Services, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
  • Translational Research Institute, Brisbane, Australia.
  • Nephrology Division, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
  • Nephrology Division, Department of Transplant Medicine, Mayo Clinic, Jacksonville, Florida.

ORCID-Profile: Isabel G Scalia, Juan M Farina, Girish Pathangey, Ramzi Ibrahim, Nima Baba Ali, Said Alsidawi, Hicham Z El Masry, Dan Sorajja, Luis R Scott, Kwan S Lee, Yeoungjee Cho, David W Johnson, Samy M Riad, Hani M Wadei, Chieh-Ju Chao, Girish K Mour, Reza Arsanjani

Zitieren

APA

Scalia, I. G., Farina, J. M., Abdelnabi, M. H., Pereyra Pietri, M., Pathangey, G., Ibrahim, R., Awad, K., Tiseer Abbas, M., Baba Ali, N., Mahmoud, A. K., Alsidawi, S., Steidley, D. E., El Masry, H. Z., Sorajja, D., Scott, L. R., Lee, K. S., Cho, Y., Johnson, D. W., Riad, S. M., …, & Arsanjani, R. (2026). Artificial Intelligence–Electrocardiography to Predict Incident Atrial Fibrillation and Clinical Outcomes in Kidney Transplant Recipients. Kidney360. https://doi.org/10.34067/kid.0000001063

Vancouver

Scalia IG, Farina JM, Abdelnabi MH, Pereyra Pietri M, Pathangey G, Ibrahim R, et al. Artificial Intelligence–Electrocardiography to Predict Incident Atrial Fibrillation and Clinical Outcomes in Kidney Transplant Recipients. Kidney360. 2026. doi:10.34067/kid.0000001063

BibTeX
@article{Scalia2026,
  author = {Scalia, Isabel G and Farina, Juan M and Abdelnabi, Mahmoud H and Pereyra Pietri, Milagros and Pathangey, Girish and Ibrahim, Ramzi and Awad, Kamal and Tiseer Abbas, Mohammed and Baba Ali, Nima and Mahmoud, Ahmed K and Alsidawi, Said and Steidley, D Eric and El Masry, Hicham Z and Sorajja, Dan and Scott, Luis R and Lee, Kwan S and Cho, Yeoungjee and Johnson, David W and Riad, Samy M and Wadei, Hani M and Lester, Steven J and Chao, Chieh-Ju and Oh, Jae K and Ayoub, Chadi and Mour, Girish K and Arsanjani, Reza},
  title = {Artificial Intelligence–Electrocardiography to Predict Incident Atrial Fibrillation and Clinical Outcomes in Kidney Transplant Recipients},
  journal = {Kidney360},
  year = {2026},
  doi = {10.34067/kid.0000001063}
}
Kostenlos starten →